Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer
about
Fluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formationDNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of CancerAutophagy in airway diseases: a new frontier in human asthma?Potential roles for prions and protein-only inheritance in cancerDifferential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagySmall-molecule inhibitors of the PI3K signaling networkHigh-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenesK-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivo.Inhibition of phosphotidylinositol-3 kinase pathway by a novel naphthol derivative of betulinic acid induces cell cycle arrest and apoptosis in cancer cells of different origin.SGK3 mediates INPP4B-dependent PI3K signaling in breast cancerReceptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.Ras signaling contributes to survival of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) Tax-positive T-cells.cAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH2-terminal kinaseInvention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor.Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.Anti-cancer Therapies in High Grade Gliomas.Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.Loss of PI3K blocks cell-cycle progression in a Drosophila tumor model.Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.Lup-20(29)-en-3β,28-di-yl-nitrooxy acetate affects MCF-7 proliferation through the crosstalk between apoptosis and autophagy in mitochondria.INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway.Burkholderia cenocepacia Induces Macropinocytosis to Enter Macrophages.KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
P2860
Q21558503-A6E4EFDA-2029-4AFE-968C-B4B0B873B5C2Q26776513-FBCD995E-7167-4204-874D-31566A7CBE4DQ26786115-8416B421-7F41-48FD-BCE2-73B90DB94FDDQ26825056-EECB3378-D0DC-4ECB-BB3D-4B395C8F32B4Q28081735-85CBF0DB-8BCC-4B7F-9DF1-03AA4D114D2AQ33883982-0C9D1A2C-BEE4-4998-B9FC-A1F4AA49AB4CQ34050186-3E346312-A0F8-4CD8-B416-6281FD246004Q34406302-E5FBAE53-A0FA-462A-8FBC-90044301EAC6Q34541519-11FF9C8A-74C9-495A-9A1A-EAA300547DEDQ34629544-36D875D3-D9EA-489F-BE9C-F60325E7A106Q35129307-3FA61F4D-2F2B-4591-83B9-1D7A1BF1C2EBQ35757427-37E2CC1E-E393-4F40-AFA1-0C825264A0ECQ35760713-758C8D00-D034-4083-B838-C6C24BE49247Q35962099-FBFEB4F0-F8D6-44AD-ACD8-37BBA4D639F7Q36115675-B832BACB-F71D-40F2-B7EB-8A0140484943Q37290626-055E21E5-1C07-48C1-BF2F-9EF83C5257EBQ37515114-0059EE97-FFC7-4771-B527-524DF62B3506Q38742022-0131E73C-421A-41B4-8F5A-B3258E1F544AQ39343270-A0DD9DB7-A5DF-49CD-8130-AAEC6E6ED986Q47072687-1FF74E14-6817-47B2-81E1-C881AA9057DBQ47547587-B62248F7-3DA3-40F1-A034-69ECA1842CB7Q52694940-2330B0B3-555C-4BB6-93CA-BCEE82DFAEB8Q54260083-EB6D934A-EADC-401A-A5E3-B0FB0A853DE3Q55044583-D055BD4E-C831-4E55-AC70-5252CA786B92Q55263196-ACB4387C-9E96-414A-A803-A2CE335E46F0
P2860
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer
@en
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer.
@nl
type
label
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer
@en
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer.
@nl
prefLabel
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer
@en
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer.
@nl
P2860
P1476
Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer
@en
P2093
Geoffrey I Shapiro
James M Cleary
P2860
P2888
P356
10.1007/S11912-010-0091-6
P577
2010-03-01T00:00:00Z